Daniel MacLachlan - 28 Nov 2023 Form 4 Insider Report for Red Violet, Inc. (RDVT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
30 Nov 2023, 18:30:08 UTC
Prior SEC filing
10 Oct 2023
Next SEC filing
01 Oct 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel MacLachlan

Key filing fact

Daniel MacLachlan filed Form 4 for Red Violet, Inc. (RDVT) on 30 Nov 2023.

Key facts

  • This page summarizes Daniel MacLachlan's Form 4 filing for Red Violet, Inc. (RDVT).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 30 Nov 2023, 18:30.

Change

  • Previous filing in this sequence was filed on 10 Oct 2023.
  • Current net transaction value: -$200,605.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RDVT transaction

Common Stock

Award

Transaction value
Shares
+23,334
Change %
+6.8%
Price
Shares after
364,425
Date
28 Nov 2023
Ownership
Direct
Footnotes
F1, F2, F3
RDVT transaction

Common Stock

Tax liability

Transaction value
$200,605
Shares
-9,882
Change %
-2.7%
Price
$20.30
Shares after
354,543
Date
28 Nov 2023
Ownership
Direct
Footnotes
F2, F3, F4
RDVT transaction

Common Stock

Gift

Transaction value
Shares
-2,500
Change %
-0.71%
Price
Shares after
352,043
Date
28 Nov 2023
Ownership
Direct
Footnotes
F2, F3, F5
RDVT transaction

Common Stock

Award

Transaction value
Shares
+40,000
Change %
+11%
Price
Shares after
392,043
Date
30 Nov 2023
Ownership
Direct
Footnotes
F2, F3, F6
RDVT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
466
Date
28 Nov 2023
Ownership
Held by IRA
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents the third vesting of 10,000 restricted stock units (RSUs) of the grant originally approved by the Company's Compensation Committee on November 20, 2020 and the first vesting of 13,334 RSUs of the grant originally approved by the Company's Compensation Committee on October 12, 2022.

Footnote F2

Includes 10,833 RSUs originally granted on September 24, 2021, convertible into common stock of the issuer on a one-for-one basis, which vests on October 1, 2024, subject to accelerated vesting under certain conditions.

Footnote F3

Includes 26,666 RSUs originally granted on October 12, 2022, convertible into common stock of the issuer on a one-for-one basis, which vest in two equal installments on each of November 1, 2024 and November 1, 2025, subject to accelerated vesting under certain conditions.

Footnote F4

Represents the disposition to issuer for tax obligations upon the vesting of RSUs.

Footnote F5

This transaction represented a gift/charitable donation effective November 28, 2023, to a qualified religious and educational organization. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.

Footnote F6

On November 30, 2023, the reporting person received a grant of 40,000 RSUs convertible into common stock of the issuer on a one-for-one basis, which vest in three equal installments on each of December 1, 2024, December 1, 2025 and December 1, 2026, subject to accelerated vesting under certain circumstances.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .